Sophie Rigaudeau

Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia

J.-V. Malfuson, A. Etienne, Pascal Turlure et al. · Haematologica · 2008 · 140 citations · Full text

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Michaël Loschi, Raphaël Porcher, Fiorenza Barraco et al. · American Journal of Hematology · 2015 · 137 citations · Full text

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

Bob Löwenberg, Petra Muus, Gert J. Ossenkoppele et al. · Blood · 2011 · 121 citations · Full text

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity

C. Charbonnel, R. Convers-Domart, Sophie Rigaudeau et al. · European Heart Journal - Cardiovascular Imaging · 2016 · 106 citations

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Thierry Façon, Christopher P. Venner, Nizar J. Bahlis et al. · Blood · 2021 · 94 citations · Full text